Angélique Bruyer

431 total citations
16 papers, 298 citations indexed

About

Angélique Bruyer is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Angélique Bruyer has authored 16 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Angélique Bruyer's work include Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (7 papers) and Cancer Mechanisms and Therapy (3 papers). Angélique Bruyer is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (7 papers) and Cancer Mechanisms and Therapy (3 papers). Angélique Bruyer collaborates with scholars based in France, Germany and United States. Angélique Bruyer's co-authors include Jérôme Moreaux, Alboukadel Kassambara, Laure Vincent, Nicolas Robert, Michel Jourdan, Bernard Klein, Guillaume Cartron, Olivier Elemento, Dirk Hose and Guilhem Requirand and has published in prestigious journals such as Nucleic Acids Research, Blood and British Journal of Cancer.

In The Last Decade

Angélique Bruyer

16 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angélique Bruyer France 10 234 110 59 59 53 16 298
Mio Yamamoto‐Sugitani Japan 10 219 0.9× 129 1.2× 95 1.6× 65 1.1× 94 1.8× 18 363
Lucia Di Marzo Italy 6 178 0.8× 150 1.4× 49 0.8× 69 1.2× 106 2.0× 7 277
Melanie Dujka United States 7 223 1.0× 48 0.4× 43 0.7× 56 0.9× 122 2.3× 12 344
Valentina Fragliasso Italy 9 176 0.8× 45 0.4× 41 0.7× 46 0.8× 74 1.4× 25 295
Y-T Tai United States 7 291 1.2× 98 0.9× 75 1.3× 21 0.4× 74 1.4× 8 367
Mariana L. Oliveira Portugal 8 131 0.6× 59 0.5× 71 1.2× 39 0.7× 78 1.5× 10 292
Sherif Ibrahim United States 6 328 1.4× 132 1.2× 54 0.9× 88 1.5× 97 1.8× 6 459
L-F Chen United States 6 320 1.4× 109 1.0× 60 1.0× 41 0.7× 111 2.1× 6 363
Dalia Quwaider Spain 10 266 1.1× 129 1.2× 25 0.4× 121 2.1× 90 1.7× 14 357
Valentina Agnusdei Italy 10 205 0.9× 69 0.6× 39 0.7× 44 0.7× 65 1.2× 11 316

Countries citing papers authored by Angélique Bruyer

Since Specialization
Citations

This map shows the geographic impact of Angélique Bruyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angélique Bruyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angélique Bruyer more than expected).

Fields of papers citing papers by Angélique Bruyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angélique Bruyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angélique Bruyer. The network helps show where Angélique Bruyer may publish in the future.

Co-authorship network of co-authors of Angélique Bruyer

This figure shows the co-authorship network connecting the top 25 collaborators of Angélique Bruyer. A scholar is included among the top collaborators of Angélique Bruyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angélique Bruyer. Angélique Bruyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bruyer, Angélique, Hugues de Boussac, Thibaut Martin, et al.. (2023). Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma. Frontiers in Oncology. 13. 1271847–1271847. 3 indexed citations
2.
Ovejero, Sara, Laurie Herviou, Hugues de Boussac, et al.. (2022). Comprehensive characterization of the epigenetic landscape in Multiple Myeloma. Theranostics. 12(4). 1715–1729. 17 indexed citations
3.
Requirand, Guilhem, Nicolas Robert, Laure Vincent, et al.. (2022). EZH2 Targeting Induces CD38 Upregulation and Response to Anti-CD38 Antibodies in Multiple Myeloma. Blood. 140(Supplement 1). 4220–4221. 1 indexed citations
4.
Kassambara, Alboukadel, Angélique Bruyer, Nicolas Robert, et al.. (2021). RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma. Journal of Personalized Medicine. 11(10). 988–988. 9 indexed citations
5.
Boussac, Hugues de, Alboukadel Kassambara, Claire Gourzonès, et al.. (2021). Genomic Characterization of in Vitro Acquired-Resistance to Proteasome Inhibitors. Blood. 138(Supplement 1). 2651–2651. 1 indexed citations
6.
Herviou, Laurie, Hugues de Boussac, Giorgio L. Papadopoulos, et al.. (2020). Comprehensive Characterization of the Epigenetic Landscape in Multiple Myeloma. Blood. 136(Supplement 1). 2–3. 3 indexed citations
7.
Jourdan, Michel, Nicolas Robert, Guilhem Requirand, et al.. (2019). Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance. Theranostics. 9(2). 540–553. 47 indexed citations
8.
Boussac, Hugues de, Angélique Bruyer, Michel Jourdan, et al.. (2019). Kinome expression profiling to target new therapeutic avenues in multiple myeloma. Haematologica. 105(3). 784–795. 34 indexed citations
9.
Kassambara, Alboukadel, et al.. (2019). Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact. Journal of Clinical Medicine. 8(7). 1074–1074. 9 indexed citations
10.
Bruyer, Angélique, Ken Maes, Laurie Herviou, et al.. (2018). DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells. British Journal of Cancer. 118(8). 1062–1073. 32 indexed citations
11.
Klein, Bernard, Jihane Basbous, Christophe Hirtz, et al.. (2017). RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. Leukemia. 31(10). 2104–2113. 64 indexed citations
12.
Kassambara, Alboukadel, Michel Jourdan, Angélique Bruyer, et al.. (2017). Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell. Nucleic Acids Research. 45(10). 5639–5652. 32 indexed citations
13.
Schoenhals, Matthieu, Michel Jourdan, Angélique Bruyer, et al.. (2017). Hypoxia favors the generation of human plasma cells. Cell Cycle. 16(11). 1104–1117. 14 indexed citations
14.
Schoenhals, Matthieu, Cecilia Frecha, Angélique Bruyer, et al.. (2012). Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins. Leukemia. 26(7). 1663–1670. 10 indexed citations
15.
Audo, Rachel, et al.. (2011). Mechanisms and clinical relevance of TRAIL‐triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis. Arthritis & Rheumatism. 63(4). 904–913. 19 indexed citations
16.
Audo, Rachel, Dominique Baeten, Angélique Bruyer, et al.. (2011). Mechanisms and clinical relevance of TRAIL-triggered responses in synovial fibroblasts of rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 70. A33–A34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mio Yamamoto‐Sugitani Breakdown of academic impact, for papers by Lucia Di Marzo Breakdown of academic impact, for papers by Melanie Dujka Breakdown of academic impact, for papers by Valentina Fragliasso Breakdown of academic impact, for papers by Y-T Tai Breakdown of academic impact, for papers by Mariana L. Oliveira Breakdown of academic impact, for papers by Sherif Ibrahim Breakdown of academic impact, for papers by L-F Chen Breakdown of academic impact, for papers by Dalia Quwaider Breakdown of academic impact, for papers by Valentina Agnusdei
Rankless by CCL
2026